LIVE VIEW · TSHATaysha Gene Therapies, Inc.BiotechnologyTSHA research Sign up to open the full interactive terminal, save boards, and get alerts
TSHA · Live chart
Loading live chart
TSHA · Smart-money compositeas of Aug 14
+6NEUTRALsmart-money positioning
-100 short0+100 long
Insiderno insider cluster in the l...
Congressno congressional trade in t...
13F fundsLONG
Short volumeFINRA short-volume is not c...
1 of 4 families contributing
TSHA · Recent signals
Q2-2026: Missed consensus by 9.3%, EPS $-0.13 vs $-0.1189 estimateMEDIUMSHORTAug 13
Q4-2025: Beat consensus by 18.5% - EPS $-0.08 vs $-0.0981 estimateMEDIUMLONGMay 17
Q1-2026: Missed consensus by 20.5% - EPS $-0.12 vs $-0.0996 estimateMEDIUMSHORTMay 17
Q2-2025: Missed consensus by 9.1% - EPS $-0.09 vs $-0.0825 estimateMEDIUMSHORTMay 17
TSHA · Institutional holdersas of 2025Q3
Point72 Asset Management, L.P.$24.0Mn/a
D. E. Shaw & Co., Inc.$22.1M+48.3%
Point72 Asset Management, L.P.$21.3M-47.2%
D. E. Shaw & Co., Inc.$19.8M+10.3%
MILLENNIUM MANAGEMENT LLC$17.5M+720.6%
MILLENNIUM MANAGEMENT LLC$14.7M+3.2%
D. E. Shaw & Co., Inc.$8.9Mn/a
TWO SIGMA INVESTMENTS, LP$3.3M+111.3%
Live alerts on TSHA
Live alerts on TSHAGet pinged the moment insiders, congress, or 13F funds move on TSHA.Sign up to unlock
Options positioning and dealer gamma
Options positioning and dealer gammaDealer gamma, call and put walls, and expiry pressure for TSHA.Sign up to unlock
Build your own board
Build your own boardEvery ticker, your own layout, saved boards, and alerts in one terminal.Sign up to unlock